171 related articles for article (PubMed ID: 11967542)
21. The generation of thymus-independent germinal centers depends on CD40 but not on CD154, the T cell-derived CD40-ligand.
Gaspal FM; McConnell FM; Kim MY; Gray D; Kosco-Vilbois MH; Raykundalia CR; Botto M; Lane PJ
Eur J Immunol; 2006 Jul; 36(7):1665-73. PubMed ID: 16783845
[TBL] [Abstract][Full Text] [Related]
22. The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching.
Jabara H; Laouini D; Tsitsikov E; Mizoguchi E; Bhan A; Castigli E; Dedeoglu F; Pivniouk V; Brodeur S; Geha R
Immunity; 2002 Sep; 17(3):265-76. PubMed ID: 12354380
[TBL] [Abstract][Full Text] [Related]
23. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling.
Jacquot S; Kobata T; Iwata S; Morimoto C; Schlossman SF
J Immunol; 1997 Sep; 159(6):2652-7. PubMed ID: 9300684
[TBL] [Abstract][Full Text] [Related]
24. TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells.
Grammer AC; Swantek JL; McFarland RD; Miura Y; Geppert T; Lipsky PE
J Immunol; 1998 Aug; 161(3):1183-93. PubMed ID: 9686578
[TBL] [Abstract][Full Text] [Related]
25. Kinase MEKK1 is required for CD40-dependent activation of the kinases Jnk and p38, germinal center formation, B cell proliferation and antibody production.
Gallagher E; Enzler T; Matsuzawa A; Anzelon-Mills A; Otero D; Holzer R; Janssen E; Gao M; Karin M
Nat Immunol; 2007 Jan; 8(1):57-63. PubMed ID: 17143273
[TBL] [Abstract][Full Text] [Related]
26. Distinct molecular mechanism for initiating TRAF6 signalling.
Ye H; Arron JR; Lamothe B; Cirilli M; Kobayashi T; Shevde NK; Segal D; Dzivenu OK; Vologodskaia M; Yim M; Du K; Singh S; Pike JW; Darnay BG; Choi Y; Wu H
Nature; 2002 Jul; 418(6896):443-7. PubMed ID: 12140561
[TBL] [Abstract][Full Text] [Related]
27. LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation.
Duhen T; Pasero C; Mallet F; Barbarat B; Olive D; Costello RT
Eur J Immunol; 2004 Dec; 34(12):3534-41. PubMed ID: 15549770
[TBL] [Abstract][Full Text] [Related]
28. CD40 and its crucial role as a member of the TNFR family.
Vogel LA; Noelle RJ
Semin Immunol; 1998 Dec; 10(6):435-42. PubMed ID: 9826576
[TBL] [Abstract][Full Text] [Related]
29. CD40-mediated signals inhibit the binding of TNF receptor-associated factor 2 to the CD40 cytoplasmic domain.
Chaudhuri A; Orme S; Eilam S; Cherayil BJ
J Immunol; 1997 Nov; 159(9):4244-51. PubMed ID: 9379019
[TBL] [Abstract][Full Text] [Related]
30. The CD40 antigen and its ligand.
Banchereau J; Bazan F; Blanchard D; Brière F; Galizzi JP; van Kooten C; Liu YJ; Rousset F; Saeland S
Annu Rev Immunol; 1994; 12():881-922. PubMed ID: 7516669
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract][Full Text] [Related]
32. Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis.
Seijkens TTP; van Tiel CM; Kusters PJH; Atzler D; Soehnlein O; Zarzycka B; Aarts SABM; Lameijer M; Gijbels MJ; Beckers L; den Toom M; Slütter B; Kuiper J; Duchene J; Aslani M; Megens RTA; van 't Veer C; Kooij G; Schrijver R; Hoeksema MA; Boon L; Fay F; Tang J; Baxter S; Jongejan A; Moerland PD; Vriend G; Bleijlevens B; Fisher EA; Duivenvoorden R; Gerdes N; de Winther MPJ; Nicolaes GA; Mulder WJM; Weber C; Lutgens E
J Am Coll Cardiol; 2018 Feb; 71(5):527-542. PubMed ID: 29406859
[TBL] [Abstract][Full Text] [Related]
33. Differential TRAF3 utilization by a variant human CD40 receptor with enhanced signaling.
Peters AL; Bishop GA
J Immunol; 2010 Dec; 185(11):6555-62. PubMed ID: 21041727
[TBL] [Abstract][Full Text] [Related]
34. Natural IgM is produced by CD5- plasma cells that occupy a distinct survival niche in bone marrow.
Reynolds AE; Kuraoka M; Kelsoe G
J Immunol; 2015 Jan; 194(1):231-42. PubMed ID: 25429072
[TBL] [Abstract][Full Text] [Related]
35. Molecular basis for CD40 signaling mediated by TRAF3.
Ni CZ; Welsh K; Leo E; Chiou CK; Wu H; Reed JC; Ely KR
Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10395-9. PubMed ID: 10984535
[TBL] [Abstract][Full Text] [Related]
36. The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling.
Donners MM; Beckers L; Lievens D; Munnix I; Heemskerk J; Janssen BJ; Wijnands E; Cleutjens J; Zernecke A; Weber C; Ahonen CL; Benbow U; Newby AC; Noelle RJ; Daemen MJ; Lutgens E
Blood; 2008 May; 111(9):4596-604. PubMed ID: 18195092
[TBL] [Abstract][Full Text] [Related]
37. The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease.
O'Connor BP; Gleeson MW; Noelle RJ; Erickson LD
Immunol Rev; 2003 Aug; 194():61-76. PubMed ID: 12846808
[TBL] [Abstract][Full Text] [Related]
38. Long-lived bone marrow plasma cells are induced early in response to T cell-independent or T cell-dependent antigens.
Bortnick A; Chernova I; Quinn WJ; Mugnier M; Cancro MP; Allman D
J Immunol; 2012 Jun; 188(11):5389-96. PubMed ID: 22529295
[TBL] [Abstract][Full Text] [Related]
39. CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms.
Grammer AC; Lipsky PE
Adv Immunol; 2000; 76():61-178. PubMed ID: 11079098
[No Abstract] [Full Text] [Related]
40. CD138 mediates selection of mature plasma cells by regulating their survival.
McCarron MJ; Park PW; Fooksman DR
Blood; 2017 May; 129(20):2749-2759. PubMed ID: 28381397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
